Clinical Trials Logo

External Anogenital Warts clinical trials

View clinical trials related to External Anogenital Warts.

Filter by:
  • None
  • Page 1

NCT ID: NCT03532776 Completed - Clinical trials for External Anogenital Warts

Comparison Between Podofilox Topical Gel 0.5% and Allergan's Condylox® Gel 0.5% for External Anogenital Warts

Start date: April 20, 2018
Phase: Phase 3
Study type: Interventional

A clinical endpoint bioequivalence (BE) study for a Podofilox Gel 0.5% formulation for the treatment of external anogenital warts in comparison to Condylox® Gel 0.5% that follows the study design and recommendations according to Office of Generic Drugs (OGD) of U.S. Food and Drug Administration (FDA) Draft Guidance for Podofilox recommendations

NCT ID: NCT01111344 Completed - Clinical trials for External Anogenital Warts

Glizigen-Viudid-External Anogenital Warts in Children and Adolescents

Start date: December 2010
Phase: Phase 3
Study type: Interventional

The purpose of the study is to assess the efficacy of Glizigen and Viusid administration in the treatment of external anogenital warts in children and adolescents. The duration of this double-blind placebo controlled phase 3 clinical trial will be 12 weeks. The estimated number of persons to be recruited and randomized for the study is 76. Variables to be assessed will be: time to disappearance of lesions, reduction of the number of lesions and change in the aspect of lesions.